Evidence map›Paper›PMID 39798055›Full record

SynthesisJournal of prevention (2022)2025

Systematic Review on Chemsex: Advocating for Inclusive Research and Primary Prevention.

Carolina Rodríguez-González, Andrea Vázquez-Martínez, Víctor José Villanueva-Blasco

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of prevention (2022), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carolina Rodríguez-GonzálezFaculty of Health Sciences, Valencian International University, Pintor Sorolla 21, 46002, Valencia, Spain.
Andrea Vázquez-MartínezFaculty of Health Sciences, Valencian International University, Pintor Sorolla 21, 46002, Valencia, Spain.
Víctor José Villanueva-BlascoFaculty of Health Sciences, Valencian International University, Pintor Sorolla 21, 46002, Valencia, Spain. vjvillanueva@universidadviu.com.ORCID 0000-0001-6081-1583

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemsex is a specific practice of sexualized drug use (SDU), linked mainly to the group of men who have sex with men (MSM). This practice has become a public health problem due to the increase in sexually transmitted infections and HIV. However, there are groups and aspects that require greater visibility and research. This study aims to (1) analyze whether the majority of existing studies on chemsex focus on MSM and to what extent studies have addressed other sexual orientations and gender identities; and (2) determine the characteristics and effectiveness of interventions implemented for the prevention and risk reduction associated with chemsex, excluding pre- and post-exposure prophylaxis for HIV. Following PRISMA recommendations, a systematic review was conducted in the Cochrane Library, PubMed/MEDLINE, Scopus and Web of Science databases between April and July 2024. The results were synthesized using a narrative approach and the methodological quality was evaluated of the studies included with the Mixed Methods Appraisal Tool (MMAT) instrument. The first search identified 1314 studies, 14 of them being relevant. The studies analyzed the presence of chemsex and SDU in diverse samples regarding sexual orientation and gender identity. They were plural and addressed multiple aspects that constitute the phenomenon of chemsex. The second search yielded 1985 studies, of which two met the inclusion criteria. No primary or secondary prevention interventions were recorded; however, risk prevention interventions were documented. These interventions demonstrated reductions in chemsex practices, engagement in unsafe sexual behaviors, and substance use. Chemsex reflects complex dynamics within sexually minoritized groups, influenced by gender, sexual orientation, and the collective's inherent insecurities. While risk reduction programs exist, there is a notable lack of primary prevention interventions. Expanding research to include diverse populations and developing inclusive strategies to address this phenomenon is crucial.

Indexed as

Homosexuality, MalePrimary PreventionSubstance-Related DisordersChemsexHIV InfectionsHumansMaleSexual and Gender MinoritiesSexual BehaviorSexually Transmitted DiseasesChemsexPreventionRisk reductionSexualized drug useSexual orientation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.